NEW YORK (GenomeWeb) – Personalis and the Precision Medicine Program at Louisiana State University Health Sciences Center New Orleans have partnered to provide comprehensive clinical genomic testing for tumor profiling and inherited genetic disease.
Personalis will perform clinical cancer testing and research services through its ACE CancerPlus test, which combines DNA and RNA sequencing of more than 1,300 genes and uses Personalis' proprietary Accuracy and Content Enhanced (ACE) technology. The test will provide comprehensive tumor genomic profile data to guide therapy and ongoing research at the Precision Medicine Program.
The company will also provide its ACE Clinical Exome test for the diagnosis of genetic disorders in both pediatric and adult patients. The ACE Clinical Exome test targets essentially all human genes using Personalis' ACE exome technology.
The partners will also collaborate "on various research projects that will be focused on enhancing patient care and outcomes, including the areas of immune-oncology and liquid biopsies," Lucio Miele, professor and chair of the Department of Genetics at LSU Health New Orleans School of Medicine, said in a statement.